The enzyme is thought to be released from neuronal and glial tissues into the blood when cell membrane integrity is lost, while the blood-brain barrier is often compromised in stroke patients, the determination of serum NSE level may be a method to predict the prognosis of brain damage [5]. This evidence concerns the gene ENO2 and stroke disorder.